Floatz logo

Cpx-351

Gray Zone Lymphoma

Children's Hospital Medical Center, CincinnatiPhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

29 Active assets in the Gray Zone Lymphoma cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
University of Washington
Phase 2BB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
University of Washington
Phase 2BB
PREDNISONE TABLETS
University of Washington
Phase 2BB
Inno-206
University of Washington
Phase 2BB
ETOPOSIDE
University of Washington
Phase 2BB

View all 39 →

Same molecule, other indications

Cpx-351 is also rated in:

therapy related acute myeloid leukemia and myelodysplastic syndromeDormant
BB
Indicative ·
67 / 100
View asset →
Secondary Acute Myeloid LeukemiaDormant
BB
Indicative ·
67 / 100
View asset →
myelodysplastic syndromeDormant
B
Indicative ·
63 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →